Lv1
20 积分 2023-10-02 加入
New prognostic indicators in surgery
2天前
已完结
Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease
2天前
待确认
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer
4个月前
已完结
Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study
4个月前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
4个月前
已完结
A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer: Presentation of safety data
4个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
4个月前
已完结
Translocation of vaginal and cervical low-abundance non-Lactobacillus bacteria notably associate with endometriosis: A pilot study
1年前
已完结
Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis
1年前
已完结
Cervical cancer – State of the science: From angiogenesis blockade to checkpoint inhibition
1年前
已完结
皖公网安备34019202002308
